Skip to Main Content

Author Details

Ling Xie
2009
52
21
PMIDPaper TitleJournal TitlePublished Year
36538511Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer.J Med Chem2023
38019706Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer.J Med Chem2023
37774414Methylated Nucleotide-Based Proteolysis-Targeting Chimera Enables Targeted Degradation of Methyl-CpG-Binding Protein 2.J Am Chem Soc2023
37858336Non-canonical function of histone methyltransferase G9a in the translational regulation of chronic inflammation.Cell Chem Biol2023
37028406Activation of hypothalamic-enhanced adult-born neurons restores cognitive and affective function in Alzheimer's disease.2023
37141574Telomere Targeting Chimera Enables Targeted Destruction of Telomeric Repeat-Binding Factor Proteins.J Am Chem Soc2023
36448571Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets.J Am Chem Soc2022
35969644Nonlytic cellular release of hepatitis A virus requires dual capsid recruitment of the ESCRT-associated Bro1 domain proteins HD-PTP and ALIX.PLoS Pathog2022
35837138Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2.ACS Pharmacol Transl Sci2022
36286484Nonlytic Quasi-Enveloped Hepatovirus Release Is Facilitated by pX Protein Interaction with the E3 Ubiquitin Ligase ITCH.Journal of Virology2022
36347944Histone H3 proline 16 hydroxylation regulates mammalian gene expression.Nat Genet2022
36197750Novel Allosteric Inhibitor-Derived AKT Proteolysis Targeting Chimeras (PROTACs) Enable Potent and Selective AKT Degradation in KRAS/BRAF Mutant Cells.J Med Chem2022
35786952TF-DUBTACs Stabilize Tumor Suppressor Transcription Factors.J Am Chem Soc2022
34855399Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders.J Med Chem2021
33644773Protocol for proteogenomic dissection of intronic splicing enhancer interactome for prediction of individualized cancer prognosis.STAR Protocols2021
33854241Author Correction: AIM2 in regulatory T cells restrains autoimmune diseases.Nature2021
34100597TF-PROTACs Enable Targeted Degradation of Transcription Factors.J Am Chem Soc2021
33505023AIM2 in regulatory T cells restrains autoimmune diseases.Nature2021
34301793AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B.Cancer Discov2021
34520194Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation.J Am Chem Soc2021
34795874Discovery and Development of Cyclic Peptide Inhibitors of CIB1.ACS Medicinal Chemistry Letters2021
34568836Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders.Nat Cancer2021
32787082Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders.J Med Chem2020
31895569Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders.J Med Chem2020
31810986TBK1 Is a Synthetic Lethal Target in Cancer with Loss.Cancer Discovery2020
33355139CRL4[DCAF1/VprBP] E3 ubiquitin ligase controls ribosome biogenesis, cell proliferation, and development.Sci Adv2020
33236014Novel gene-specific translation mechanism of dysregulated, chronic inflammation reveals promising, multifaceted COVID-19 therapeutics.bioRxiv2020
33284613Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders.J Med Chem2020
31146747Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.BMC Medical Genomics2019
31730343Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader.J Med Chem2019
31729379Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer.Nat Commun2019
31336272Multi-omic Dissection of Oncogenically Active Epiproteomes Identifies Drivers of Proliferative and Invasive Breast Tumors.iScience2019
29503206Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer.Cell Chemical Biology2018
30026228VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma.Science2018
30446383RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs.Immunity2018
28440318Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.Nat Commun2017
28348404Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.Nat Commun2017
28854366The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology.Cell Reports2017
28490497Protein composition of the hepatitis A virus quasi-envelope.Proceedings of the National Academy of Sciences of the United States of America2017
26631509An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.Mol Cell Proteomics2016
27112199Proteomic dissection of LPS-inducible, PHF8-dependent secretome reveals novel roles of PHF8 in TLR4-induced acute inflammation and T cell proliferation.Scientific Reports2016
26598639QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues.Molecular and Cellular Proteomics2016
26119999Non-canonical Bromodomain within DNA-PKcs Promotes DNA Damage Response and Radioresistance through Recognizing an IR-Induced Acetyl-Lysine on H2AX.Chem Biol2015
23448259Whole human genome proteogenomic mapping for ENCODE cell line data: identifying protein-coding regions.BMC Genomics2013
23434512Protein phosphatase 2A catalytic subunit α plays a MyD88-dependent, central role in the gene-specific regulation of endotoxin tolerance.Cell Reports2013
23030679GOFAST: an integrated approach for efficient and comprehensive membrane proteome analysis.Analytical Chemistry2012
22833098BCLAF1 is a radiation-induced H2AX-interacting partner involved in γH2AX-mediated regulation of apoptosis and DNA repair.Cell Death and Disease2012
22955977Long noncoding RNAs are rarely translated in two human cell lines.Genome Res2012
20696126An optimized magnetite microparticle-based phosphopeptide enrichment strategy for identifying multiple phosphorylation sites in an immunoprecipitated protein.Analytical Biochemistry2011
21220426Unambiguous characterization of site-specific phosphorylation of leucine-rich repeat Fli-I-interacting protein 2 (LRRFIP2) in Toll-like receptor 4 (TLR4)-mediated signaling.Journal of Biological Chemistry2011
  • 1 - 50 of 52

Recommended Authors

Collaborators

Co-authored papers 48
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Co-authored papers 20
Co-authored papers 12
Co-authored papers 8
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
University of North Carolina
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Washington University in St Louis
Co-authored papers 3
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
McDonnell Genome Institute, Washington University in St. Louis
Co-authored papers 3
Co-authored papers 3
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers 3
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Broad Institute of MIT and Harvard
Co-authored papers 3
Massachusetts Institute of Technology, USA Broad Institute
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of North Carolina
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2